Interpretation of Chinese and foreign guidelines for the diagnosis and management of nonalcoholic fatty liver disease / 中国实用内科杂志

ABSTRACT

With the prevalence of obesity and metabolic syndrome(MetS), nonalcoholic fatty liver disease(NAFLD) instead of chronic hepatitis B has been the most common cause of chronic liver disease in China. In order to standardize the diagnosis and treatment of NAFLD, the Fatty Liver Expert Committee of Chinese Medical Association issued “The guideline of prevention and treatment for nonalcoholic fatty liver disease” in March 2018, which was similar to the latest NAFLD Guidelines published by the AASLD, EASL and Asia-Pacific working party in the recent two years, but was different in details owing to the distinct condition of different countries. The purpose of the article is to help clinicians understand the guidelines more comprehensively and profoundly and guide their clinical work according to the interpretation of Chinese and overseas NAFLD guidelines.